CAS 1185887-14-2
:N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
Description:
N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide is a synthetic compound characterized by its complex structure, which includes an indazole core, an amide functional group, and various substituents that contribute to its biological activity. The presence of the amino and carboxamide groups suggests potential for hydrogen bonding, influencing its solubility and interaction with biological targets. The phenylmethyl and cyclohexylmethyl groups may enhance lipophilicity, affecting the compound's pharmacokinetics and ability to cross biological membranes. This compound is of interest in medicinal chemistry, particularly for its potential therapeutic applications, possibly in the realm of neuropharmacology or oncology. Its specific stereochemistry, indicated by the (1S) configuration, may also play a crucial role in its biological activity and receptor interactions. As with many synthetic compounds, understanding its stability, reactivity, and metabolic pathways is essential for evaluating its safety and efficacy in potential applications.
Formula:C24H28N4O2
InChI:InChI=1S/C24H28N4O2/c25-23(29)20(15-17-9-3-1-4-10-17)26-24(30)22-19-13-7-8-14-21(19)28(27-22)16-18-11-5-2-6-12-18/h1,3-4,7-10,13-14,18,20H,2,5-6,11-12,15-16H2,(H2,25,29)(H,26,30)/t20-/m0/s1
InChI key:InChIKey=DMHWDSGURMXMGE-FQEVSTJZSA-N
SMILES:C(N1C=2C(C(C(N[C@@H](CC3=CC=CC=C3)C(N)=O)=O)=N1)=CC=CC2)C4CCCCC4
Synonyms:- N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
- 1H-Indazole-3-carboxamide, N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-(cyclohexylmethyl)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
PX-3 (APP-CHMINACA)
CAS:Controlled ProductPX-3 (APP-CHMINACA) is an amide type synthetic cannabinoid that has a CB2 receptor affinity profile. It is one of the most potent synthetic cannabinoids from the group of phenylacetylpiperidines, with a potency that is 10 to 100 times greater than other related compounds. PX-3 is metabolized in vivo and produces metabolites that are detectable in human liver samples. The metabolism of this compound generates monohydroxylated metabolites which are not found in natural cannabinoids. Synthetic cannabinoids such as PX-3 can have significant health effects on humans, including cardiovascular disease and cancer.Purity:Min. 95%APP-CHMINACA RM
CAS:Controlled Product<p>Applications APP-CHMINACA RM, in a synthetic cannabinoid (CB) that has shown a 10-fold greater affinity for the central CB1 receptor (Ki = 0.9 nM) than that of JWH 018 (P283650).Synthetic Cannabinoids<br>References Uchiyama, N., Forensic Toxicol. 31(1), 93-100 (2013).;<br></p>Formula:C24H28N4O2Color and Shape:NeatMolecular weight:404.50

